Vaccine Access Negotiations to Resume as New Variants Spread
3 years ago
UNITED NATIONS, Aug 30 (IPS) – A committee that has spent almost a year negotiating the terms of a temporary intellectual property waiver for Covid-19 medicines will reconvene in September after pausing for the European Summer.